Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05919511 · ClinicalTrials.gov registry record
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
A clinical trial of cGVHD, sponsored by Incyte Corporation.
- Recruiting
- Registry status
- 1,500
- Enrollment target
- 20
- Study locations
NCT05919511 is a study of cGVHD that is actively recruiting participants, run by Incyte Corporation. The registered enrollment target is 1,500 participants, above the 24-participant average among 3 other cGVHD trials with a reported enrollment target (6150% higher). The trial reports 20 study locations across 13 states.
The verdict
NCT05919511, a study of cGVHD, is actively recruiting participants, sponsored by Incyte Corporation.
- RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this prospective observational study is to collect data from participants who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of Chronic Graft Versus Host Disease(cGVHD)
Conditions Studied
Interventions
- OTHER Non-Interventional
Study Locations (20)
Illinois
- Northwestern University - Chicago
- Rush University Medical Group - Chicago
- The University of Chicago - Chicago
- Loyola University Medical Center - Maywood
Florida
- Mayo Clinic Jacksonville - Jacksonville
- AdventHealth Orlando - Orlando
- Moffit Cancer Center - Orlando
California
- City of Hope - Duarte
- USC Norris Comprehensive Cancer Center - Los Angeles
Georgia
- Emory University - Atlanta
- Georgia Cancer Center - Augusta
Alabama
- University of Alabama Birmingham - Birmingham
Arizona
- Mayo Clinic Arizona - Phoenix
Colorado
- University of Colorado - Aurora
Kansas
- The University of Kansas Clinical Research Center - Fairway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2027-10-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05919511
The ClinicalTrials.gov registry entry for NCT05919511 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 24-participant average among 3 other cGVHD trials with a reported enrollment target (6150% higher). The listed sponsor is Incyte Corporation, which has 239 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with cGVHD appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional is the first listed.
NCT05919511 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Illinois, Florida, California.
Frequently Asked Questions
What is clinical trial NCT05919511 about?
NCT05919511 is a clinical study titled "Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease". The purpose of this prospective observational study is to collect data from participants who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of Chronic Graft Versus Host Disease(cGVHD)
What is the current status of trial NCT05919511?
This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2023-08-01. Estimated completion is 2027-10-15.
What conditions does trial NCT05919511 study?
This clinical trial studies the following conditions: cGVHD.
What interventions are being tested in trial NCT05919511?
The interventions under investigation include: Non-Interventional (OTHER).
Who is sponsoring clinical trial NCT05919511?
This trial is sponsored by Incyte Corporation, which has 239 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05919511 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for cGVHD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease
RECRUITING · Phase 2
-
Tele-Palliative Care Intervention for Patients With Chronic Graft-Versus-Host Disease
ACTIVE NOT RECRUITING · NA
-
Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.